Hansen Medical, Inc., a global leader in intravascular robotics, will showcase its new Sensei® X2 Robotic System prototype at Cardiostim Congress from June 18 - 21 at the Acropolis Convention Center in Nice, France. The Sensei X2 features faster image processing and a slimmer design with the stability and reachability of its predecessor.
The improved processing and imaging capabilities of the Sensei X2 will also be available to users of the current Sensei X upon release. The Company anticipates commercialization of the Sensei X2 in the second half of the year.
Kim Rajappan, MD, John Radcliffe Hospital will present "Clinical Experience with Sensei Robotic System" in the Hansen booth F12 on Wednesday, June 18 at 15:30 and Friday, June 20 at 10:30. Dr. Rajappan's presentation will share his clinical experiences with the Sensei Robotic Catheter System and discuss the role of intravascular robotics in ablation procedures.
"Hansen is committed to educating physicians on the benefits of robotics for intravascular procedures," said Cary Vance, President and CEO of Hansen Medical. "Dr. Rajappan's presentation will illustrate the significant benefits to both patients and physicians made possible by the Sensei Robotic System."
For a hands-on product demonstration of the Sensei X2 Robotic System prototype, register here and visit Cardiostim booth F12.
About Sensei® X Robotic Catheter System
Through continued advancement of medical robotics, Hansen Medical has developed a next generation minimally-invasive, robotic catheter system, the Sensei X Robotic Catheter System which combines advanced levels of 3D catheter control and 3D visualization. This unique, state of the art technology has been used in over 10,000 patients, and is powered by a robotically controlled arm that allows for catheter navigation, stability and positioning within the patient's heart atria, allowing for the following system advantages:
- Catheter Stability with Force-Sensing;
- Instinctive 3D Control; and
- Reduced Fluoro Time for Physician.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, is a global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, 9Fr Magellan™ Robotic Catheter, Magellan™ 6Fr Robotic Catheter, and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan 9Fr Robotic Catheter has undergone both CE marking and 510(k) clearance and is commercially available in the European Union, and the U.S. The Magellan 6Fr Robotic Catheter has undergone 510(k) clearance in the U.S. and is in limited release for the next several months in anticipation of more wide-scale commercially availability later in 2014. In the European Union, the Company's Sensei® X Robotic Catheter System and Artisan® and Artisan Extend® Control Catheters are cleared for use during electrophysiology (EP) procedures, such as guiding catheters in the treatment of atrial fibrillation (AF), and the Lynx® Robotic Ablation Catheter is cleared for the treatment of AF. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the U.S., the Company's Sensei X Robotic Catheter System and Artisan and Artisan Extend Control Catheters are cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in EP procedures. In the U.S., the Sensei X Robotic Catheter System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei X Robotic Catheter System and Artisan and Artisan Extend Control Catheter for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including AF, have not been established.